ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES

抗逆转录病毒治疗和长期临床结果

基本信息

  • 批准号:
    6510209
  • 负责人:
  • 金额:
    $ 12.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-04-01 至 2004-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (adapted from the application s abstract): Recent advances in antiretroviral therapy have dramatically changed the treatment and clinical outcomes for persons with HIV infection. The goal of therapy has expanded from delaying HIV disease progression and death to suppressing viral replication below the level of quantitation for as long as possible to permit immunologic improvement and clinical stabilization. However, now there is a growing proportion of patients who cannot maintain viral suppression often despite changing and more complex therapeutic regimens. The candidate hypothesis s that in the clinic setting, in contrast to the clinical trials setting, a steadily increasing proportion of patients will not have sustained suppression of viral replication over the long-term. Better definition of the generic relationship between longitudinal urologic and immunologic measures and long-term clinical outcomes across the enormous number of antiretroviral combinations available, will become increasingly essential to clinicians. In addition, there is a need to assess potential survival benefits of early and prolonged potent antiretroviral treatment in relation to the long-term effects of treatment-related events, such as neuropathy and metabolic complications (e.g. hyperlipidemia, hyperglycemia), on health-related quality-of-life and quality-adjusted survival. To complement and extend information available from clinical efficacy trials, the investigator proposes an epidemiological investigation of predictors of AIDS-free survival and quality-adjusted survival among HIV infected individuals receiving potent combination antiretroviral therapies. For this purpose, she has developed a computerized medical information system at the University of Washington that captures real-time clinical practice information for an HIV clinic population in the Northwest. Collection of comprehensive longitudinal information about HIV infected patients in this clinic setting, may enable the candidate to develop sets of measures of virologic, immunologic, and clinical responses to potent antiretroviral treatment that best predict long-term clinical outcomes. The mentoring and additional training provided by the Mentored Patient-Oriented Research Award will provide the candidate with an opportunity to devote significant efforts to research questions using the clinical information system and to develop the skills necessary to pursue a research career that blends epidemiological approaches and health services research.
描述(改编自申请摘要):……的最新进展

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARI M KITAHATA其他文献

MARI M KITAHATA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARI M KITAHATA', 18)}}的其他基金

3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
3/4 HIV 酒精研究联盟 - 流行病学研究部门 (ARCH-ERA)
  • 批准号:
    8211460
  • 财政年份:
    2011
  • 资助金额:
    $ 12.57万
  • 项目类别:
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
3/4 HIV 酒精研究联盟 - 流行病学研究部门 (ARCH-ERA)
  • 批准号:
    8527634
  • 财政年份:
    2011
  • 资助金额:
    $ 12.57万
  • 项目类别:
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
3/4 HIV 酒精研究联盟 - 流行病学研究部门 (ARCH-ERA)
  • 批准号:
    8333978
  • 财政年份:
    2011
  • 资助金额:
    $ 12.57万
  • 项目类别:
Clinical Epidemiology and Health Services Research
临床流行病学和卫生服务研究
  • 批准号:
    7479032
  • 财政年份:
    2008
  • 资助金额:
    $ 12.57万
  • 项目类别:
Core-Health Services
核心健康服务
  • 批准号:
    6896692
  • 财政年份:
    2004
  • 资助金额:
    $ 12.57万
  • 项目类别:
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES
抗逆转录病毒治疗和长期临床结果
  • 批准号:
    6147585
  • 财政年份:
    2000
  • 资助金额:
    $ 12.57万
  • 项目类别:
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES
抗逆转录病毒治疗和长期临床结果
  • 批准号:
    6631671
  • 财政年份:
    2000
  • 资助金额:
    $ 12.57万
  • 项目类别:
ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMES
抗逆转录病毒治疗和长期临床结果
  • 批准号:
    6372702
  • 财政年份:
    2000
  • 资助金额:
    $ 12.57万
  • 项目类别:
Core G: Clinical and Comorbidity Research
核心 G:临床和合并症研究
  • 批准号:
    10671225
  • 财政年份:
    1997
  • 资助金额:
    $ 12.57万
  • 项目类别:
Core G: Clinical Cohort and Comorbidity Research
核心 G:临床队列和合并症研究
  • 批准号:
    10170239
  • 财政年份:
    1997
  • 资助金额:
    $ 12.57万
  • 项目类别:

相似海外基金

Basic and applied study on AIDS-therapy using hybrid liposomes
混合脂质体治疗艾滋病的基础与应用研究
  • 批准号:
    24656509
  • 财政年份:
    2012
  • 资助金额:
    $ 12.57万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
SIV MODEL FOR MULTI DRUG RESISTANCE TO AIDS THERAPY
艾滋病治疗多重耐药性的 SIV 模型
  • 批准号:
    6940442
  • 财政年份:
    2003
  • 资助金额:
    $ 12.57万
  • 项目类别:
RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
艾滋病治疗抵抗力的 RT-SHIV 模型
  • 批准号:
    6940441
  • 财政年份:
    2003
  • 资助金额:
    $ 12.57万
  • 项目类别:
Mitochondrial Toxicity of Antiviral Nucleosides in AIDS Therapy
艾滋病治疗中抗病毒核苷的线粒体毒性
  • 批准号:
    7421121
  • 财政年份:
    2002
  • 资助金额:
    $ 12.57万
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7479315
  • 财政年份:
    2001
  • 资助金额:
    $ 12.57万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6312501
  • 财政年份:
    2001
  • 资助金额:
    $ 12.57万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6499098
  • 财政年份:
    2001
  • 资助金额:
    $ 12.57万
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7666728
  • 财政年份:
    2001
  • 资助金额:
    $ 12.57万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6708893
  • 财政年份:
    2001
  • 资助金额:
    $ 12.57万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6849724
  • 财政年份:
    2001
  • 资助金额:
    $ 12.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了